AFP and hepatocellular carcinoma: The first study performed in 267 HCC patients reported an AUC of 0.858, with a sensitivity of 80.77% and a specificity of 68.09%, using precontrast and contrast-enhanced MRI with gadopentetate dimeglumine and two clinical factors (arterial peritumoral enhancement and AFP) [51].